Home Cart Sign in  
Chemical Structure| 20034-00-8 Chemical Structure| 20034-00-8

Structure of 20034-00-8

Chemical Structure| 20034-00-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 20034-00-8 ]

CAS No. :20034-00-8
Formula : C8H7N3O3
M.W : 193.16
SMILES Code : OCC1=NC2=C(N1)C=CC(=C2)[N+]([O-])=O
MDL No. :MFCD00462582
InChI Key :ZJLPIDVKNQXTKN-UHFFFAOYSA-N
Pubchem ID :3744471

Safety of [ 20034-00-8 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 20034-00-8 ] Show Less

Physicochemical Properties

Num. heavy atoms 14
Num. arom. heavy atoms 9
Fraction Csp3 0.12
Num. rotatable bonds 2
Num. H-bond acceptors 4.0
Num. H-bond donors 2.0
Molar Refractivity 51.04
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

94.73 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.73
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.91
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.81
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.58
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.34
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.31

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.95
Solubility 2.14 mg/ml ; 0.0111 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.48
Solubility 0.633 mg/ml ; 0.00327 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.12
Solubility 1.45 mg/ml ; 0.0075 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.83 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.09

Application In Synthesis of [ 20034-00-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 20034-00-8 ]
  • Downstream synthetic route of [ 20034-00-8 ]

[ 20034-00-8 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 79-14-1 ]
  • [ 99-56-9 ]
  • [ 20034-00-8 ]
YieldReaction ConditionsOperation in experiment
87% at 130℃; for 3 h; General procedure: To a mixture of 1a–1c (10 mmol) with glycolic acid (2.28 g, 30 mmol) was added concentrated H3PO4(20 mL). The reaction mixture was refluxed at 130°C for 3 h, then quenched with 20percent NaOH. The respective solid product was collected by filtration.
References: [1] Russian Journal of General Chemistry, 2017, vol. 87, # 12, p. 3006 - 3016.
[2] Bulletin of the Korean Chemical Society, 2013, vol. 34, # 4, p. 1272 - 1274.
[3] Molecules, 2015, vol. 20, # 8, p. 15206 - 15223.
[4] Journal of the American Chemical Society, 1952, vol. 74, p. 3689.
[5] Journal of the American Chemical Society, 1957, vol. 79, p. 4391,4393.
[6] Patent: US2004/209865, 2004, A1, .
[7] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 2, p. 933 - 936.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 20034-00-8 ]

Alcohols

Chemical Structure| 4856-97-7

A101376 [4856-97-7]

(1H-Benzoimidazol-2-yl)methanol

Similarity: 0.81

Chemical Structure| 39811-07-9

A573610 [39811-07-9]

(5-Fluoro-1H-benzo[d]imidazol-2-yl)methanol

Similarity: 0.69

Chemical Structure| 540516-28-7

A241766 [540516-28-7]

2-(Hydroxymethyl)-5-bromobenzimidazole

Similarity: 0.66

Chemical Structure| 41292-66-4

A117193 [41292-66-4]

2-Methyl-1H-benzo[d]imidazol-5-ol

Similarity: 0.66

Chemical Structure| 6758-34-5

A137317 [6758-34-5]

(5-(Trifluoromethyl)-1H-benzo[d]imidazol-2-yl)methanol

Similarity: 0.66

Nitroes

Chemical Structure| 76320-88-2

A226948 [76320-88-2]

2-Methyl-4-nitro-1H-benzo[d]imidazole

Similarity: 0.82

Chemical Structure| 1792-40-1

A143755 [1792-40-1]

2-Methyl-5-nitro-1H-benzo[d]imidazole

Similarity: 0.79

Chemical Structure| 73903-18-1

A244846 [73903-18-1]

5-Nitro-1H-benzo[d]imidazole-2-carboxylic acid

Similarity: 0.79

Chemical Structure| 25045-82-3

A114991 [25045-82-3]

6-Nitroimidazo[1,2-a]pyridine

Similarity: 0.68

Chemical Structure| 1571-85-3

A242287 [1571-85-3]

6-Nitro-2-phenyl-1H-benzo[d]imidazole

Similarity: 0.67

Related Parent Nucleus of
[ 20034-00-8 ]

Benzimidazoles

Chemical Structure| 76320-88-2

A226948 [76320-88-2]

2-Methyl-4-nitro-1H-benzo[d]imidazole

Similarity: 0.82

Chemical Structure| 4856-97-7

A101376 [4856-97-7]

(1H-Benzoimidazol-2-yl)methanol

Similarity: 0.81

Chemical Structure| 1792-40-1

A143755 [1792-40-1]

2-Methyl-5-nitro-1H-benzo[d]imidazole

Similarity: 0.79

Chemical Structure| 73903-18-1

A244846 [73903-18-1]

5-Nitro-1H-benzo[d]imidazole-2-carboxylic acid

Similarity: 0.79

Chemical Structure| 39811-07-9

A573610 [39811-07-9]

(5-Fluoro-1H-benzo[d]imidazol-2-yl)methanol

Similarity: 0.69